Worldwide, WHO has estimated in 2005 that out of 17 million deaths, 2/3 occurs in low and medium income countries including India[@ref1][@ref2]. Deaths in India are due to heart disease in 29 per cent and there has been a 7-fold increase in 4 decades (1960-2000) of the prevalence of IHD in epidemiological studies[@ref3]. Risk factors have been the subject of many studies, dominated by hypertension, diabetes and smoking with multiple risk factors being in the majority[@ref3]. However, in 10-20 per cent of cases, there is no obvious risk factor apart from the traditional and newer risk factors[@ref3].

Infection has been suspected as a probable cause because of raised total leucocyte count (TLC), C-reactive protein (CRP), ESR and fibrinogen levels, in the acute coronary syndrome[@ref4]. There have been several studies in industrialized countries[@ref5]--[@ref9] linking infection with coronary artery disease (CAD). Ieren *et al*[@ref10] have shown the results for and against the assumption of infection. There have been four studies conducted in India in the recent past in this area[@ref11]--[@ref14].

We carried out this study to determine the relationship, if any of infections with suspected infective agents *e.g. Chlamydia pneumoniae*, cytomegalovirus (CMV), *Helicobactor pylori, Mycoplasma pneumoniae* and parvovirus B-19 with coronary artery disease (CAD) among Indians.

Material & Methods {#sec1-1}
==================

This study was carried out at National Heart Insitute (NHI) of the All India Heart Foundation (AIHF), New Delhi, between 2000-2004. The Scientific Advisory Research & Ethics Committee of the All India Heart Foundation/National Heart Institute (NHI), New Delhi cleared the proposal. Written consent was taken from all the patients.

*Selection of subjects*: Consecutive patients with CAD attending outpatient department of NHI during the study period were selected for the study.

(1)Patients of unequivocal acute myocardial infarction (AMI) (Group I, N=200). These were the most likely subjects to show infection, if any.(2)Normal controls (Group II, N=200). These were age matched controls selected from the Executive Check-up Wellness Programme of the NHI.(3)Patients subjected to coronary artery bypass graft (CABG) (Group III, N=168)). These were proven cases of CAD ([Table I](#T1){ref-type="table"}). At the time of surgery, aortic tissue was obtained and evidence of infection was looked for. Only 168 subjects could be included in this group though originally planned to include 200. Aorta punch biopsies could be obtained only in 70 patients.

###### 

Age/sex distribution of patients and control groups
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A special proforma was designed to record the clinical history of all subjects. Essential biochemical tests \[glucose, lipid profile, kidney & liver function and inflammatory tests (total leucocyte count, TLC, C-reactive protein, CRP and fibrinogen)\] were performed in the biochemistry laboratory of the National Heart Institute.

Serological evidence of chronic infection (IgG, IgA) was obtained by using standard test kits available commercially. ELISA(Savyon Diagnostic, Israel; Vircell SL., Spain; Pathozme, UK; Vir-Immun-Labor Diagnostika, Germany; Virion/Serion ELISA Classic, Germany; RIDASCREEN-Biopharm, Germany; Eurogenetics, Belgium), microimmunofluorescence (Vircell SL., Spain), direct immunofluorescence (Dako, Imagen, Denmark), latex agglutination (Ranbaxy, India)\]. *C . pneumonia* antigen was also determined by fluorescent antibody test in 18 of 70 aortic biopsies tested. Eight of the 18 tissue biopsies were tested for antigen by DFA and because of negative results by PCR. PCR and DFA were carried out at the Chalmydia Reference Centre, All India Institute of Medical Sciences (AIIMS), New Delhi and immunoflorescence at the NHI, New Delhi.

The aortic endothelial tissues were collected in phosphate buffered saline (PBS) for immunofluorescence from patients undergoing CABG surgery and stored at -- 70° C till further testing[@ref11]. The slide was mounted with the mounting fluid and viewed under the fluorescent microscope (Nikon Corp., Japan) using 490 nm filters for the detection of the *C. pneumoniae* antigen. The positive and negative controls supplied with the kit were stained simultaneously. Multiple polymerase chain reaction (PCR) studies were also carried out on endothelial biopsies for *C. pneumoniae*, CMV, Enteroviruses and Parvo B-19.

*Statistical analysis*: Univariate analysis was carried out to estimate the odds ratio and comparison between A ml0 patients and controls using SPSS Software System . T test was used for comparison? between the groups. Multiple logistic regressions by unconditional -- conditional method was done to compare titres of *C. pneumoniae* antibodies in patients and controls at 95 per cent confidence interval.

Results {#sec1-2}
=======

Maximum number of patients and controls were in the 40-50 yr age group. Male predominance was noted in all three groups ([Table I](#T1){ref-type="table"}).

Comparison of the lipid profile in AMI patients (group I) and controls (group II) showed a significant difference (*P*\<0.001) in HDL cholesterol (\< 35 mg/dl), and Lipid Tetrad Index, triglycerides level (*P*\<0.01) and lipoprotein (a) (*P*\< 0.05) ([Table II](#T2){ref-type="table"}).

###### 

Risk factors in AMI patients and controls

![](IJMR-135-228-g002)

Among the known cardiac risk factors triglycerides were found to be significantly (*P*\<0.001) higher in *C. pneumoniae* seropositive compared to seronegatives. Low LDL and higher levels of HDL and total cholesterol levels were also seen (*P*\<0.05) in *C. pneumoniae* seropositive group compared to seronegative group ([Table III](#T3){ref-type="table"}).

###### 

Comparison of some known cardiac risk factors with *C. pneumoniae* seropositivitly
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There was no significant difference between the patients and controls with regard to IgG and IgA antibodies with any of the infective agents. Only 6.8 per cent AMI patients showed Parvovirus B antibodies (IgG), no kits were available for IgA ([Table IV](#T4){ref-type="table"}).

###### 

IgG/IgA antibodies in AMI patients and controls to some chronic infective agents
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A follow up of eight patients where repeated samples were tested after 6 months to 2 years, no change in *C. pneumoniae* IgG, IgA antibody titres was observed. These antibodies persisted for a long time perhaps due to the presence of the *C. pneumoniae* in the tissues leading to chronic active infection.

*C. pneumoniae* antigen was also detected by direct fluorescent antibody (DFA) test in 18 of 70 (25.7%) aortic tissue biopsies tested ([Table V](#T5){ref-type="table"}). However, no association was seen between antigen detection and seropositivity. Eight of the 18 tissue biopsies positive for antigen by DFA gave negative results by PCR. By PCR, Parvovirus B was detected in 8 of 98 (8.1%) aortic tissues tested.

###### 

Association of *C. pneumoniae* antigen in aortic endothelial tissue biopsies and antibodies to *C. pneumoniae*
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Discussion {#sec1-3}
==========

In the present study, no significant difference in *C. pneumoniae* IgA and IgG levels was seen in the two groups (AMI and control). Similar results have been reported earlier[@ref5][@ref6]. Altman *et al*[@ref6] studied 159 patients with arterial atherosclerotic disease and compared the result with 203 patients with a heart valve prostheses and no demonstrable CAD. They concluded that C. pneumoniae infection was not an independent risk factor for CAD. In another prospective study, *C. pneumoniae* IgG seropositivity did not show any risk of future likelihood of myocardial infarction, and no association was found between *C. pneumoniae* infection and CAD[@ref8].

Certain lipid risk factors (triglycerides, HDL and lipid tetrad index) were significantly higher in the *Chlamydia* seropositive group compared to the seronegative group. Chlamydia induces production of several cytokines leading to altered lipid metabolism, accumulation of serum triglycerides and a decrease in HDL[@ref7]--[@ref9]. Lipopolysaccharide, a bacterial component, binds in human serum to both HDL and LDL and makes LDL toxic to endothelial cells. Cytokines are potent inducers of neutrophils and free radical generation, which may facilitate oxidation of LDL, a key event in atherogenesis. Leukocyte activation may also lead to propagation of the atherosclerotic process[@ref7][@ref10]. Our study showed an association between *C. pneumoniae* antibodies and lipid risk factors.

It has been shown that despite a seronegative status, *C. pneumoniae* can be detected in atheromatous plaques by immune-cytochemistry, cell culture and polymerase chain reaction[@ref8][@ref10]. A significant association was found between *C. pneumoniae* seropositivity and an adverse lipid profile, indicating a possible indirect effect of infection with CAD.

Satpathy & associates from India[@ref12] studied 62 end anteriotomy specimens of discarded coronary arteries of the CAD patients. Association between *C. pneumoniae* infection and CAD could not be established by genome or antigen detection. Goyal *et al*[@ref13] investigated 30 CAD patients with no conventional risk factors scheduled for CABG and healthy blood donors. *C. pneumoniae* seropositivity was significantly, higher in CAD patients.

Jha *et al*[@ref14][@ref15] screened for *C. pneumoniae, H. pylori*, CMV and HSV-1 in different vascular locations of CAD patients using quantitative real-time (RT) PCR and suggested that *C. pneumoniae* may have caused chronic persistent infection in CAD. Our study in a small number of CAD patients also suggested continuing chronic infection.

In conclusion, no direct effect of infectious agents as causal for CAD could be shown. Our results showed an association between *C. pneumoniae* seropositivity and an adverse lipid profile. Further work needs to be done to confirm whether infectious agents have any causal effect in CAD.
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